The Expression of Fibroblast Activation Protein in Clear Cell Renal Cell Carcinomas Is Associated with Synchronous Lymph Node Metastases.
The Expression of Fibroblast Activation Protein in Clear Cell Renal Cell Carcinomas Is Associated with Synchronous Lymph Node Metastases.
复制标题
DOI:
10.1371/journal.pone.0169105
复制
发表时间:
2016
期刊:
影响因子:
3.7
通讯作者:
Larrinaga G
中科院分区:
文献类型:
--
作者:
Errarte P;Guarch R;Pulido R;Blanco L;Nunes-Xavier CE;Beitia M;Gil J;Angulo JC;López JI;Larrinaga G
Clear cell renal cell carcinoma (CCRCC) is a heterogeneous and complex disease that frequently develops distant metastases. Fibroblast activation protein (FAP) is a serine peptidase the expression of which in cancer-associated fibroblasts has been associated with higher risk of metastases and poor survival. The objective of this study was to evaluate the role of FAP in metastatic CCRCC (mCCRCC). A series of 59 mCCRCC retrospectively collected was included in the study. Metastases developed either synchronous (n = 14) or metachronous to renal disease (n = 45). Tumor specimens were obtained from both primary lesion (n = 59) and metastases (n = 54) and FAP expression was immunohistochemically analyzed. FAP expression in fibroblasts from primary tumors correlated with FAP expression in the corresponding metastatic lesions. Also, primary and metastatic FAP expression was correlated with large tumor diameter (>7cm), high grade (G3/4), high stage (pT3/4), tumor necrosis and sarcomatoid transformation. The expression of FAP in primary tumors and in their metastases was associated both with synchronous metastases and also with metastases to the lymph nodes. FAP expression in the primary tumor was correlated with worse 10-year overall survival. Immunohistochemical detection of FAP in the stromal tumor fibroblasts could be a biomarker of early lymph node metastatic status and therefore could account for the poor prognosis of FAP positive CCRCC.
登录
查看更多内容
影响因子:
3.3
作者:
Bostrom, Anna-Karin;Moller, Christina;Johansson, Martin E.
通讯作者:
Johansson, Martin E.
DOI:
10.1002/pros.23145
发表时间:
2016-05
期刊:
The Prostate
影响因子:
--
作者:
Brennen WN;Kisteman LN;Isaacs JT
通讯作者:
Isaacs JT
影响因子:
10.3
作者:
Brennen, W. Nathaniel;Rosen, D. Marc;Denmeade, Samuel R.
通讯作者:
Denmeade, Samuel R.
影响因子:
6.6
作者:
Leibovich, BC;Cheville, JC;Blute, ML
通讯作者:
Blute, ML
影响因子:
4.2
作者:
Augoff, Katarzyna;Hryniewicz-Jankowska, Anita;Sikorski, Aleksander F.
通讯作者:
Sikorski, Aleksander F.